ORBIMED ADVISORS LLC

Holdings History for X4 Pharmaceuticals, Inc - Common Stock, par value $0.001 per share (XFOR)

Symbol: XFOR on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share
Latest Disclosed Shares Owned: 134,947 shares
Security Ownership %: 1.7%

Shares, Excluding Options vs Price

Value, Excluding Options

ORBIMED ADVISORS LLC ownership in X4 Pharmaceuticals, Inc Common Stock, par value $0.001 per share (XFOR)

14 Aug 2025 - ORBIMED ADVISORS LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 134,947 shares of X4 Pharmaceuticals, Inc Common Stock, par value $0.001 per share (XFOR). This represents 1.7% ownership of the company. This is the first filing by ORBIMED ADVISORS LLC disclosing ownership of X4 Pharmaceuticals, Inc Common Stock, par value $0.001 per share (XFOR).

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
ORBIMED ADVISORS LLC	1.7%		$25,640	134,947			$0.19	13G/A	30 Jun 2025	14 Aug 2025, 17:53

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Jun 2025		-0.04%	$0	0	-6,776,515	-100%	$4.00	Q2 2025
31 Mar 2025	0.04%	-0%	$1,601,968	6,776,515	-357,000		$0.24	Q1 2025
31 Dec 2024	0.11%	0%	$5,233,147	7,133,515	0		$0.73	Q4 2024
30 Sep 2024	0.09%	0%	$4,774,462	7,133,515	0		$0.67	Q3 2024
30 Jun 2024	0.09%	0%	$4,137,439	7,133,515	0		$0.58	Q2 2024
31 Mar 2024	0.2%	0%	$9,915,586	7,133,515	0		$1.39	Q1 2024
31 Dec 2023	0.12%	0%	$5,981,452	7,133,515	0		$0.84	Q4 2023
30 Sep 2023	0.18%	0%	$7,775,531	7,133,515	0		$1.09	Q3 2023
30 Jun 2023	0.27%	+0.05%	$13,839,019	7,133,515	+1,315,789	+23%	$1.94	Q2 2023
31 Mar 2023	0.1%	0%	$5,061,422	5,817,726	0		$0.87	Q1 2023
31 Dec 2022	0.12%	+0.02%	$5,777,002	5,817,726	+790,909	+16%	$0.99	Q4 2022
30 Sep 2022	0.17%	+0.13%	$8,596,000	5,026,817	+3,652,968	+266%	$1.71	Q3 2022
30 Jun 2022	0.03%	0%	$1,326,000	1,373,849	0		$0.97	Q2 2022
31 Mar 2022	0.04%	0%	$2,404,000	1,373,849	0		$1.75	Q1 2022
31 Dec 2021	0.04%	0%	$3,146,000	1,373,849	0		$2.29	Q4 2021
30 Sep 2021	0.08%	0%	$7,268,000	1,373,849	0		$5.29	Q3 2021
30 Jun 2021	0.09%	0%	$8,930,000	1,373,849	0		$6.50	Q2 2021
31 Mar 2021	0.12%	+0.02%	$11,829,000	1,373,849	+287,356	+26%	$8.61	Q1 2021
31 Dec 2020	0.06%	0%	$6,986,000	1,086,493	0		$6.43	Q4 2020
30 Sep 2020	0.09%	0%	$7,356,000	1,086,493	0		$6.77	Q3 2020
30 Jun 2020	0.14%	0%	$10,126,000	1,086,493	0		$9.32	Q2 2020
31 Mar 2020	0.18%	0%	$10,865,000	1,086,493	0		$10.00	Q1 2020
31 Dec 2019	0.17%	+0.02%	$11,625,000	1,086,493	+150,000	+16%	$10.70	Q4 2019
30 Sep 2019	0.23%	0%	$11,903,000	936,493	0		$12.71	Q3 2019
30 Jun 2019	0.22%	+0.15%	$14,047,000	936,493	+625,000	+201%	$15.00	Q2 2019
31 Mar 2019	0.09%	+0.09%	$5,423,000	311,493	+311,493	NEW	$17.41	Q1 2019

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.